FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Pollak

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Physiology

Living Beings

Mouse

Concepts & Ideas

Risk Factors

Co-author Network

Publications

TOP 3
Michael Pollak
Targeting oxidative phosphorylation: why, when, and how.
Henning Hvid; Elena Birman; Marie-José Blouin; Sarah-Maria Fendt; Russell Frank; Bo Falck Hansen; Gregory Stephanopoulos; Angela Manegold Svendsen; Matthew G Vander Heiden; Gregory Voisin; Michael Pollak
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway.
Carly Jade Dool; Marco Gottardis; Haider Mashhedi; Elena Birman; Marie-José Blouin; Joan M Carboni; Stéphanie David; Mahvash Zakikhani; Yunhua Zhao; Michael Pollak
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Pollak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael Pollak
Targeting oxidative phosphorylation: why, when, and how.
Cancer cell 2013;23(3):263-4.
2012: Henning Hvid; Elena Birman; Marie-José Blouin; Sarah-Maria Fendt; Russell Frank; Bo Falck Hansen; Gregory Stephanopoulos; Angela Manegold Svendsen; Matthew G Vander Heiden; Gregory Voisin; Michael Pollak
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway.
Endocrine-related cancer 2012;19(4):557-74.
2011: Carly Jade Dool; Marco Gottardis; Haider Mashhedi; Elena Birman; Marie-José Blouin; Joan M Carboni; Stéphanie David; Mahvash Zakikhani; Yunhua Zhao; Michael Pollak
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer.
Endocrine-related cancer 2011;18(6):699-709.
2011: Samy Suissa; J Vora; Laurent Y Azoulay; Sophie Dell'Aniello; M Evans; Michael Pollak
Long-term effects of insulin glargine on the risk of breast cancer.
Diabetologia 2011;54(9):2254-62.
2011: Haider Mashhedi; Mahvash Zakikhani; Yunhua Zhao; Carolyn Algire; Antonio Aliaga; Miguel Bazile; Barry J Bedell; Elena Birman; Marie-José Blouin; Stéphanie David; Michael Pollak
Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet.
Cell cycle (Georgetown, Tex.) 2011;10(16):2770-8.
2011: Matei Mireuta; Mark A Hancock; Michael Pollak
Binding between insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 is not influenced by glucose or 2-deoxy-D-glucose.
The Journal of biological chemistry 2011;286(19):16567-73.
2011: Laurent Azoulay; Sophie Dell'Aniello; Bruno Gagnon; Michael Pollak; Samy Suissa
Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(2):337-44.
2011: Cristina E Tognon; Aruna M Somasiri; Valentina E Evdokimova; Genny Trigo; Evett E Uy; Nataliya Melnyk; Joan M Carboni; Marco M Gottardis; Calvin D Roskelley; Michael Pollak; Poul H B Sorensen
ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
Cancer research 2011;71(3):1060-70.
2010: Takamitsu Inoue; Mahvash Zakikhani; Stéphanie David; Carolyn Algire; Marie-José Blouin; Michael Pollak
Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in man.
The Prostate 2010;70(15):1628-35.
2010: Luc Furic; Liwei Rong; Ola Larsson; Ismaël Hervé Koumakpayi; Kaori Yoshida; Andrea Brueschke; Emmanuel Petroulakis; Nathaniel Robichaud; Michael Pollak; Louis A Gaboury; Pier Paolo Pandolfi; Fred Saad; Nahum Sonenberg
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(32):14134-9.
2010: Sarah Khalid; David Hwang; Yael Babichev; Rani Kolli; Svetlana Altamentova; Shlomit Koren; Pamela J Goodwin; Marguerite Ennis; Michael Pollak; Nahum Sonenberg; I George Fantus
Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis.
Breast cancer research and treatment 2010;122(3):647-59.
2010: Min Hou; Natalie Venier; Linda Sugar; Mireia Musquera; Michael Pollak; Alex Kiss; Neil Fleshner; Laurence Klotz; Vasundara Venkateswaran
Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet.
Biochemical and biophysical research communications 2010;397(3):537-42.
2010: Carolyn Algire; Lilian Amrein; Mahvash Zakikhani; Lawrence Panasci; Michael Pollak
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase.
Endocrine-related cancer 2010;17(2):351-60.
2010: Michael Pollak; D Russell-Jones
Insulin analogues and cancer risk: cause for concern or cause célèbre?
International journal of clinical practice 2010;64(5):628-36.
2010: Marie-José Blouin; Yunhua Zhao; Mahvash Zakikhani; Carolyn Algire; Esther Piura; Michael Pollak
Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose.
Cancer letters 2010;289(2):246-53.
2009: Michael Pollak
Macronutrient intake and cancer: how does dietary restriction influence tumor growth and why should we care?
Cancer prevention research (Philadelphia, Pa.) 2009;2(8):698-701.
2009: Sofia Avnet; Laura Sciacca; Manuela Salerno; Giovanni Gancitano; Maria Francesca Cassarino; Alessandra Longhi; Mahvash Zakikhani; Joan M Carboni; Marco Gottardis; Armando Giunti; Michael Pollak; Riccardo Vigneri; Nicola Baldini
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Cancer research 2009;69(6):2443-52.
2009: Michael E Cox; Martin E Gleave; Mahvash Zakikhani; Robert H Bell; Esther Piura; Elaine Vickers; Matthew Cunningham; Ola Larsson; Ladan Fazli; Michael Pollak
Insulin receptor expression by human prostate cancers.
The Prostate 2009;69(1):33-40.
2008: Michael Pollak
Insulin and insulin-like growth factor signalling in neoplasia.
Nature reviews. Cancer 2008;8(12):915-28.
2008: Carolyn Algire; Mahvash Zakikhani; Marie-Jose Blouin; Jian Hua Shuai; Michael Pollak
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.
Endocrine-related cancer 2008;15(3):833-9.
2008: Michael Pollak
Targeting insulin and insulin-like growth factor signalling in oncology.
Current opinion in pharmacology 2008;8(4):384-92.
2008: Caroline Diorio; Jacques Brisson; Sylvie Bérubé; Michael Pollak
Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(4):880-8.
2008: Golareh Habibi; Samuel Leung; Jennifer H Law; Karen Gelmon; Hamid Masoudi; Dmitry Turbin; Michael Pollak; Torsten O Nielsen; David Huntsman; Sandra E Dunn
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Breast cancer research : BCR 2008;10(5):R86.
2008: Caroline Diorio; Jacques Brisson; Sylvie Bérubé; Michael Pollak
Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study.
Breast cancer research : BCR 2008;10(3):R42.
2007: Ryan J O Dowling; Mahvash Zakikhani; I George Fantus; Michael Pollak; Nahum Sonenberg
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
Cancer research 2007;67(22):10804-12.
2007: Randy Levitt; Yunhua Zhao; Marie-José Blouin; Michael Pollak
The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Cancer letters 2007;255(2):300-6.
2006: Mahvash Zakikhani; Ryan Dowling; I George Fantus; Nahum Sonenberg; Michael Pollak
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
Cancer research 2006;66(21):10269-73.
2005: Randy Levitt; Maria-Magdalena Georgescu; Michael Pollak
PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2.
Biochemical and biophysical research communications 2005;336(4):1056-61.
2005: Noreen Majeed; Marie-José Blouin; Paula J Kaplan-Lefko; Jane Barry-Shaw; Norman M Greenberg; Pierrette Gaudreau; Tarek A Bismar; Michael Pollak
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.
Oncogene 2005;24(29):4736-40.
2005: Robert K Nam; John Trachtenberg; Michael A S Jewett; Ants Toi; Andrew Evans; Marjan Emami; Steven A Narod; Michael Pollak
Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1270-3.
2005: Anne Camirand; Mahvash Zakikhani; Fiona Young; Michael Pollak
Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells.
Breast cancer research : BCR 2005;7(4):R570-9.
2005: Michael Pollak
Individualizing interventions for cancer prevention.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2005;166():63-9.
2004: Anne Camirand; Michael Pollak
Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells.
British journal of cancer 2004;90(9):1825-9.
2004: Randy Levitt; Jonathan Buckley; Marie-José Blouin; Betty Schaub; Timothy Triche; Michael Pollak
Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
Biochemical and biophysical research communications 2004;316(2):421-8.
2004: Joe H Lai; Danny Vesprini; William Zhang; Martin J Yaffe; Michael Pollak; Steven A Narod
A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(4):573-82.
2004: Yuhong Lu; Xiaolin Zi; Michael Pollak
Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
International journal of cancer. Journal international du cancer 2004;108(3):334-41.
2004: Yuhong Lu; Xiaolin Zi; Yunhua Zhao; Michael Pollak
Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Biochemical and biophysical research communications 2004;313(3):709-15.
2003: Robert K Nam; William W Zhang; John Trachtenberg; Michael A S Jewett; Marjan Emami; Danny Vesprini; William Chu; Minnie Ho; Joan Sweet; Andrew Evans; Ants Toi; Michael Pollak; Steven A Narod
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1429-37.
2003: H A Ismail; Michael Pollak; Hassan Behlouli; Simon Tanguay; Louis R Bégin; Armen G Aprikian
Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples.
BJU international 2003;92(7):699-702.
2003: Edward Giovannucci; Michael Pollak; Yan Liu; Elizabeth A Platz; Noreen Majeed; Eric B Rimm; Walter C Willett
Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(2):84-9.
2002: Randy Levitt; Michael Pollak
Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
Cancer research 2002;62(24):7372-6.
2002: Anne Camirand; Yuhong Lu; Michael Pollak
Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(12):BR521-6.
2002: Hazem Ismail A; Michael Pollak; Hassan Behlouli; Simon Tanguay; Louis R Begin; Armen G Aprikian
Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy.
The Journal of urology 2002;168(6):2426-30.
2001: Yuhong Lu; Xiaolin Zi; Yunhua Zhao; D Mascarenhas; Michael Pollak
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).
Journal of the National Cancer Institute 2001;93(24):1852-7.
2001: T Nickerson; F Chang; D Lorimer; S P Smeekens; C L Sawyers; Michael Pollak
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
Cancer research 2001;61(16):6276-80.
2001: Michael Pollak; Marie-José Blouin; J C Zhang; John J Kopchick
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist.
British journal of cancer 2001;85(3):428-30.
2001: Bin He; Ron A Deckelbaum; Dengshun Miao; M L Lipman; Michael Pollak; David Goltzman; Andrew C Karaplis
Tissue-specific targeting of the pthrp gene: the generation of mice with floxed alleles.
Endocrinology 2001;142(5):2070-7.
2001: Helena Jernström; Cheri Deal; F Wilkin; William Chu; Y Tao; Noreen Majeed; T Hudson; Steven A Narod; Michael Pollak
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(4):377-84.
2001: A W Tolcher; A Kennedy; R J Padley; Noreen Majeed; Michael Pollak; Philip W Kantoff
Other novel agents: Rationale and current status as chemopreventive agents.
Urology 2001;57(4 Suppl 1):86-9.
2001: Cheri Deal; J Ma; F Wilkin; Jean Paquette; F Rozen; B Ge; T Hudson; M Stampfer; Michael Pollak
Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.
The Journal of clinical endocrinology and metabolism 2001;86(3):1274-80.
2001: Helena Jernström; William Chu; Danny Vesprini; Y Tao; Noreen Majeed; Cheri Deal; Michael Pollak; Steven A Narod
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
Molecular genetics and metabolism 2001;72(2):144-54.
2001: Michael Pollak
Insulin-like growth factors and prostate cancer.
Epidemiologic reviews 2001;23(1):59-66.
2000: Xiaolin Zi; J Zhang; R Agarwal; Michael Pollak
Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
Cancer research 2000;60(20):5617-20.
2000: C Byrne; GRaham Colditz; Walter C Willett; Frank E Speizer; Michael Pollak; Susan E Hankinson
Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
Cancer research 2000;60(14):3744-8.
2000: F Wilkin; Jean Paquette; Elisabeth Ledru; C Hamelin; Michael Pollak; Cheri Deal; C Mamelin
H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels.
European journal of biochemistry / FEBS 2000;267(13):4020-7.
2000: Edward Giovannucci; Michael Pollak; Elizabeth A Platz; Walter C Willett; Meir J Stampfer; Noreen Majeed; GRaham Colditz; Frank E Speizer; Susan E Hankinson
Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10 Suppl A():S30-1.
2000: C Byrne; Susan E Hankinson; Michael Pollak; Walter C Willett; GRaham Colditz; Frank E Speizer
Insulin-like growth factors and mammographic density.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10 Suppl A():S24-5.
2000: Michael Pollak
Insulin-like growth factor physiology and neoplasia.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10 Suppl A():S6-7.
2000: Michael Pollak
The question of a link between insulin-like growth factor physiology and neoplasia.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10 Suppl B():S21-4.
1999: T Nickerson; Michael Pollak
Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins.
Urology 1999;54(6):1120-5.
1999: F Rozen; Michael Pollak
Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
International journal of oncology 1999;15(3):589-94.
1999: T Nickerson; H Miyake; Martin E Gleave; Michael Pollak
Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
Cancer research 1999;59(14):3392-5.
1999: T Nickerson; J Zhang; Michael Pollak
Regression of DMBA-induced breast carcinoma following ovariectomy is associated with increased expression of genes encoding insulin-like growth factor binding proteins.
International journal of oncology 1999;14(5):987-90.
1998: F Rozen; J Zhang; Michael Pollak
Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.
International journal of oncology 1998;13(4):865-9.
1998: minh huynh; Michael Pollak; J C Zhang
Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089.
International journal of oncology 1998;13(1):137-43.
1998: Susan E Hankinson; Walter C Willett; GRaham Colditz; David J Hunter; D S Michaud; B Deroo; Bernard Rosner; Frank E Speizer; Michael Pollak
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Lancet 1998;351(9113):1393-6.
1998: T Nickerson; Michael Pollak; minh huynh
Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5.
Endocrinology 1998;139(2):807-10.
1998: Michael Pollak; W Beamer; J C Zhang
Insulin-like growth factors and prostate cancer.
Cancer metastasis reviews 1998;17(4):383-90.
1998: Michael Pollak
IGF-I physiology and breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():63-70.
1997: T Nickerson; minh huynh; Michael Pollak
Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells.
Biochemical and biophysical research communications 1997;237(3):690-3.
1997: F Rozen; X F Yang; minh huynh; Michael Pollak
Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.
Journal of the National Cancer Institute 1997;89(9):652-6.
1996: minh huynh; T Nickerson; Michael Pollak; X Yang
Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(12):2037-42.
1996: minh huynh; X F Yang; Michael Pollak
A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(11):1501-6.
1996: minh huynh; L Alpert; Michael Pollak
Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes.
Cancer research 1996;56(21):4865-70.
1996: minh huynh; L Alpert; Michael Pollak
Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II.
Cancer research 1996;56(16):3651-4.
1996: X F Yang; W G Beamer; minh huynh; Michael Pollak
Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
Cancer research 1996;56(7):1509-11.
1996: minh huynh; X Yang; Michael Pollak
Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells.
The Journal of biological chemistry 1996;271(2):1016-21.
1995: minh huynh; Catharina Larsson; S Narod; Michael Pollak
Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.
Cancer research 1995;55(11):2225-31.
1995: H Hung; Michael Pollak
Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: correlations with effects on proliferation: a review.
Progress in growth factor research 1995;6(2-4):495-501.
1994: minh huynh; Michael Pollak
Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.
Cancer research 1994;54(12):3115-9.
1993: minh huynh; Michael Pollak
Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
Cancer research 1993;53(23):5585-8.
1993: Patricia N Tonin; E Ehrenborg; G Lenoir; Jean Feunteun; Henry T Lynch; Kenneth Morgan; H Zazzi; A Vivier; Michael Pollak; minh huynh
The human insulin-like growth factor-binding protein 4 gene maps to chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer.
Genomics 1993;18(2):414-7.
1993: R N Pollack; Michael Pollak; Louise Rochon
Pregnancy complicated by medulloblastoma with metastases to the placenta.
Obstetrics and gynecology 1993;81(5 ( Pt 2)):858-9.
1993: minh huynh; E Tetenes; L Wallace; Michael Pollak
In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen.
Cancer research 1993;53(8):1727-30.
1992: Michael Pollak; A W Sem; M Richard; E Tetenes; R Bell
Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy.
Journal of the National Cancer Institute 1992;84(12):966-71.
1992: Gloria S Tannenbaum; W Gurd; M Lapointe; Michael Pollak
Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin.
Endocrinology 1992;130(6):3395-401.
1990: Michael Pollak; M Richard
Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
Journal of the National Cancer Institute 1990;82(16):1349-52.
1989: S Suissa; Michael Pollak; W O Spitzer; R Margolese
Body size and breast cancer prognosis: a statistical explanation of the discrepancies.
Cancer research 1989;49(11):3113-6.